Nirman Bio Pharma Private Limited

Nirman Bio Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U24299DL2021PTC376745 Incorporated 09 February 2021 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹5.45 Cr
▲ 230% YoY
Net profit · FY 2024
₹1.95 Lakh
Net margin 0.4%
EBITDA · FY 2024
₹3.24 Lakh
EBITDA margin 0.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered

About Nirman Bio Pharma Private Limited

Data last updated:

Nirman Bio Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 February 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2021PTC376745. Its GSTIN is 07AAHCN4225C1ZT (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunil Kumar and Anuradha Kumari.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No G – 18 Plot No 5 Ground Floor Cs/Ocf Rk Plaza Sec 21 Rohini Ph 3 Delhi, Delhi, India – 110086.

As per the financials filed for FY 2024, the company reported a revenue of ₹5.45 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.95 Lakh (net margin 0.4%) and EBITDA of ₹3.24 Lakh (EBITDA margin 0.6%).

Court records list 1 case involving the company, including 1 filed against it.

Company Details of Nirman Bio Pharma Private Limited
CIN U24299DL2021PTC376745
Registration Number 376745
Incorporation Date 09 February 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Shop No G – 18 Plot No 5 Ground Floor Cs/Ocf Rk Plaza Sec 21 Rohini Ph 3 Delhi, Delhi, India – 110086
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Nirman Bio Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Nirman Bio Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Nirman Bio Pharma Private Limited in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Business Activity of Nirman Bio Pharma Private Limited

The main business activity of Nirman Bio Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Nirman Bio Pharma Private Limited FY 2024 filings available

Nirman Bio Pharma Private Limited reported revenue of ₹5.45 Cr (up 230% YoY) for FY 2024.

Revenue · FY 2024
₹5.45 Cr ▲ 230%
Net profit · FY 2024
₹1.95 Lakh margin 0.4%
EBITDA · FY 2024
₹3.24 Lakh margin 0.6%

Compounded Annual Growth Rate (CAGR) of Nirman Bio Pharma Private Limited

Revenue CAGR growth
1 year
▲ 230%
EBITDA CAGR growth
1 year
▲ 144%

Revenue rose 230% in the latest year. EBITDA rose 144% in the latest year. All are worked out from the filed statements.

Financial Statement Summary of Nirman Bio Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••
Other Income••••••••••••••••
Total Revenue••••••••••••••••
Cost of Materials Consumed••••••••••••••••
Employee Benefit Expense••••••••••••••••
Finance Costs••••••••••••••••
Depreciation and Amortisation••••••••••••••••
Other Expenses••••••••••••••••
Total Expenses••••••••••••••••
EBITDA₹3.24 Lakh••••••••••••
Profit Before Tax••••••••••••••••
Tax Expense••••••••••••••••
Net Profit (PAT)₹1.95 Lakh••••••••••••
Balance Sheet
Share Capital••••••••••••••••
Reserves and Surplus••••••••••••••••
Net Worth (Total Equity)••••••••••••••••
Long-term Borrowings••••••••••••••••
Short-term Borrowings••••••••••••••••
Trade Payables••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Nirman Bio Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.6%••••••••••••
Net Profit Margin0.4%••••••••••••
Return on Equity (ROE)••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••
Return on Assets (ROA)••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Quick Ratio••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••
Interest Coverage Ratio••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Payable Days••••••••••••••••
Inventory Days••••••••••••••••
Revenue Growth••••••••••••••••
Net Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nirman Bio Pharma are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Nirman Bio Pharma Private Limited

Nirman Bio Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pushpa Ispat Private Limited₹5.45 Cr (FY 2025)••••••••-52.0%••••Hyderabad, Telangana, India
Asir Motors Private Limited₹5.45 Cr (FY 2024)••••••••91.0%••••Thoothukudi, Tamil Nadu, India
Somaay Industries Private Limited₹5.45 Cr (FY 2025)••••••••21.0%••••Kanpur, Uttar Pradesh, India
Bestco Cables Private Limited₹5.45 Cr (FY 2025)••••••••-61.0%••••Haridwar, Uttarakhand, India
Kaygee Processors Private Limited₹5.45 Cr (FY 2025)••••••••9.0%••••New Delhi, Delhi, India
Nirman Bio Pharma Private Limited this company₹5.45 Cr (FY 2024)••••••••230.0%••••Delhi, India
Rajpal Distributors Private Limited₹5.45 Cr (FY 2024)••••••••0.0%••••Udaipur, Rajasthan, India
Neha Elecon Services Private Limited₹5.45 Cr (FY 2022)••••••••8.0%••••Pune, Maharashtra, India
Nippon Distributors Private Limited₹5.45 Cr (FY 2024)••••••••38.0%••••Ahmedabad, Gujarat, India
Advanced Micro Services Private Limited₹5.45 Cr (FY 2025)••••••••-5.0%••••Bangalore, Karnataka, India
Ketti Valley Tea India Private Limited₹5.44 Cr (FY 2025)••••••••440.0%••••Tamil Nadu, India

Peers are the five companies nearest above and the five nearest below Nirman Bio Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Nirman Bio Pharma Private Limited

Nirman Bio Pharma Private Limited is audited by RAHUL GARG for the financial year 2023.

NameStatusAppointment DateCessation Date
RAHUL GARGLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Nirman Bio Pharma Private Limited

Nirman Bio Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sunil KumarDirector09 Feb 20215 Years 8 MonthsCurrent
Anuradha KumariDirector09 Feb 20215 Years 8 MonthsCurrent

Ownership and Shareholding of Nirman Bio Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Nirman Bio Pharma Private Limited

Nirman Bio Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Nirman Bio Pharma Private Limited

Nirman Bio Pharma Private Limited has a workforce of 0 employees as of Apr 03, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Nirman Bio Pharma Private Limited

Nirman Bio Pharma Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Sushil Kumar ceased to be Director on 19 Aug 2022.

AGM
Nirman Bio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Nirman Bio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi Ii.
Ceased
Sushil Kumar ceased to be Director.
Appointed
Anuradha Kumari was appointed as Director.
Appointed
Sunil Kumar was appointed as Director.
Incorporation
09 Feb 2021
Nirman Bio Pharma Private Limited was registered on 09 Feb 2021 with Roc Delhi Ii & aged 5 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Nirman Bio Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Nirman Bio Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Nirman Bio Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Nirman Bio Pharma Private Limited

Nirman Bio Pharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AAHCN4225C1ZTDelhiActive28 Aug 2021
09AAHCN4225C1ZPUttar PradeshActive28 Dec 2023
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Nirman Bio Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nirman Bio Pharma Private Limited

Nirman Bio Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 February 2021 (5+ years old) and is registered under CIN U24299DL2021PTC376745.

Nirman Bio Pharma reported revenue of ₹5.45 Cr for FY 2024 (up 230% YoY).

Nirman Bio Pharma has 2 current directors:

Nirman Bio Pharma reported a net profit of ₹1.95 Lakh (net margin 0.4%) and EBITDA of ₹3.24 Lakh (EBITDA margin 0.6%) for FY 2024, as per its filed financial statements.

The GSTIN of Nirman Bio Pharma is 07AAHCN4225C1ZT, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAHCN4225C1ZP (Uttar Pradesh).

The CIN (Corporate Identification Number) of Nirman Bio Pharma is U24299DL2021PTC376745. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nirman Bio Pharma has 1 court case on record: 1 filed against it.

Nirman Bio Pharma was incorporated on 09 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Nirman Bio Pharma by revenue are Pushpa Ispat Private Limited, Asir Motors Private Limited, Somaay Industries Private Limited, Bestco Cables Private Limited, Kaygee Processors Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).

Sushil Kumar ceased to be Director on 19 Aug 2022. Anuradha Kumari was appointed as Director on 09 Feb 2021. Sunil Kumar was appointed as Director on 09 Feb 2021.

The registered office of Nirman Bio Pharma is at Shop No G – 18 Plot No 5 Ground Floor CsOcf Rk Plaza Sec 21 Rohini Ph 3 Delhi, Delhi, India – 110086.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available